Bill

Bill > HB2176


WA HB2176

WA HB2176
Exempting information in collaborative drug therapy agreements from disclosure under the public records act.


summary

Introduced
01/12/2026
In Committee
02/02/2026
Crossed Over
Passed
Dead

Introduced Session

2025-2026 Regular Session

Bill Summary

AN ACT Relating to exempting information in collaborative drug 2 therapy agreements from disclosure under the public records act; and 3 amending RCW 42.56.360. 4

AI Summary

This bill amends the state's public records act to add a new exemption for collaborative drug therapy agreements (CDTAs), which are legal documents that outline how pharmacists can work with other healthcare providers to manage patient medications. Specifically, the bill makes CDTAs and their attachments confidential and not subject to public disclosure, with one key exception: if a CDTA becomes the basis for a disciplinary action against a licensed healthcare professional, it can be disclosed. However, even in such cases, any personally identifiable information about individuals other than the disciplined professional must remain confidential. The bill defines personally identifiable information as including names, mailing addresses, credential numbers, email addresses, and practice site facility addresses and phone numbers. This exemption is designed to protect the privacy of healthcare providers and patients involved in collaborative medication management while still allowing transparency in cases of professional misconduct. The provision falls under the broader category of health care information exemptions in the state's public records law and is governed by rules established by the pharmacy quality assurance commission.

Committee Categories

Government Affairs

Sponsors (8)

Last Action

House Rules "X" file. (on 02/19/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...